<SEC-DOCUMENT>0001214659-25-014630-index.html : 20251003
<SEC-HEADER>0001214659-25-014630.hdr.sgml : 20251003
<ACCEPTANCE-DATETIME>20251003213727
ACCESSION NUMBER:		0001214659-25-014630
CONFORMED SUBMISSION TYPE:	SCHEDULE 13D/A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20251003
DATE AS OF CHANGE:		20251003

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Alzamend Neuro, Inc.
		CENTRAL INDEX KEY:			0001677077
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				811822909
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0430

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-92615
		FILM NUMBER:		251375508

	BUSINESS ADDRESS:	
		STREET 1:		480 PEACHTREE ROAD NE, SECOND FLOOR
		STREET 2:		SUITE 103
		CITY:			ATLANTA
		STATE:			GA
		ZIP:			30326
		BUSINESS PHONE:		844-722-6333

	MAIL ADDRESS:	
		STREET 1:		480 PEACHTREE ROAD NE, SECOND FLOOR
		STREET 2:		SUITE 103
		CITY:			ATLANTA
		STATE:			GA
		ZIP:			30326

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AULT MILTON C III
		CENTRAL INDEX KEY:			0001212502
		ORGANIZATION NAME:           	
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D/A

	MAIL ADDRESS:	
		STREET 1:		11411 SOUTHERN HIGHLANDS PARKWAY
		STREET 2:		SUITE 190
		CITY:			LAS VEGAS
		STATE:			NV
		ZIP:			89141
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13D/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
Document 1 - file: primary_doc.html

Document 1 - RAW XML: primary_doc.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1
<SEQUENCE>2
<FILENAME>ex1.htm
<DESCRIPTION>EXHIBIT 1
<TEXT>
Document 2 - file: ex1.htm

</DOCUMENT>
</SEC-DOCUMENT>